2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial …
2007 Writing Committee Members, JL Anderson… - Circulation, 2013 - Am Heart Assoc
It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …
use of diagnostic procedures and therapies as they are introduced and tested in the …
Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of …
T Palmerini, U Benedetto, L Bacchi-Reggiani… - The Lancet, 2015 - thelancet.com
Background Despite recent studies, the optimum duration of dual antiplatelet therapy
(DAPT) after coronary drug-eluting stent placement remains uncertain. We performed a meta …
(DAPT) after coronary drug-eluting stent placement remains uncertain. We performed a meta …
2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on …
Writing Committee Members, JS Lawton… - Journal of the American …, 2022 - jacc.org
Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …
Short-and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from …
S Bangalore, S Kumar, M Fusaro, N Amoroso… - Circulation, 2012 - Am Heart Assoc
Background—Drug-eluting stents (DES) have been in clinical use for nearly a decade;
however, the relative short-and long-term efficacy and safety of DES compared with bare …
however, the relative short-and long-term efficacy and safety of DES compared with bare …
ACC/AHA 2007 guidelines for the management of patients with unstable angina/non–ST-elevation myocardial infarction: a report of the American College of …
JL Anderson, CD Adams, EM Antman… - Journal of the American …, 2007 - jacc.org
The ACC/AHA Task Force on Practice Guidelines was formed to make recommendations
regarding the diagnosis and treatment of patients with known or suspected cardiovascular …
regarding the diagnosis and treatment of patients with known or suspected cardiovascular …
Triggers, targets and treatments for thrombosis
N Mackman - Nature, 2008 - nature.com
Thrombosis—localized clotting of the blood—can occur in the arterial or the venous
circulation and has a major medical impact. Acute arterial thrombosis is the proximal cause …
circulation and has a major medical impact. Acute arterial thrombosis is the proximal cause …
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST …
JP Bassand, CW Hamm, D Ardissino… - European heart …, 2007 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …
for personal and educational use only. No commercial use is authorized. No part of the ESC …
ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American …
It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …
use of diagnostic procedures and therapies as they are introduced and tested in the …
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association …
CL Grines, RO Bonow, DE Casey Jr, TJ Gardner… - Circulation, 2007 - Am Heart Assoc
Dual antiplatelet therapy with aspirin and a thienopyridine has been shown to reduce
cardiac events after coronary stenting. However, many patients and healthcare providers …
cardiac events after coronary stenting. However, many patients and healthcare providers …
Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents
Importance Guidelines recommend delaying noncardiac surgery in patients after coronary
stent procedures for 1 year after drug-eluting stents (DES) and for 6 weeks after bare metal …
stent procedures for 1 year after drug-eluting stents (DES) and for 6 weeks after bare metal …